Tesamorelin

Tesamorelin is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It is used to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, a condition characterized by changes in body fat distribution.

This medication is administered via subcutaneous injection and works by stimulating the pituitary gland to produce and release growth hormone. It is intended for individuals diagnosed with HIV lipodystrophy who experience visceral adiposity, and its use is typically part of a broader treatment plan managed by healthcare professionals.